Recognizing the patient in drug development: Is your company patient centric?
Clinical trials can benefit from patient involvement in the planning and development of new therapies at an early stage. Further, it is often more economical in terms of drug development time and financial investment to add patient-centered metrics to trial protocol at an early rather than late stage of development. From First Word "Pursuing the Patient Centric Model" - a free report. Go to Firstword for copy of report.
Pharma M&A down to near 5 year low
Deals in 2017 are on pace for almost half the yearly totals of the past two years. Potential buyers await clarity surrounding tax reform. See full article here.
What social media platform does your company use?
A new study of pharmaceutical marketing teams found that the most popular social media forum groups plan to use in the next one to two years is Facebook (73%), according to data published by business intelligence firm Cutting Edge Information. Go to article to learn more.
Are HCP's are bored with your message?
Are doctors bored with the story your reps are telling? Recent DRG study highlights challenge of engaging doctors with your story. Representatives struggle even to get time in front of physicians. How compelling is the message they deliver and are you maximizing available technology and channels? “There’s a disconnect between the sales force, which is very focused on script volumes and meeting their numbers, and digital marketers, who are focused on physician engagement and b
Innovation inspiration
"I get up every morning, winter and summer at four. First I go into the woods and gather specimens, and listen to what God had to say to me. After I have had my morning talk with God, I go to my laboratory and begin to carry out His wishes for the day, and if I fail it's my failure, and if I succeed then God's will has been done."
~George Washington Carver
